BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20979731)

  • 1. [Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study].
    Chen YD; Zhao LK; Tian F; Du ZM; Jiang H; Wei M
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):473-6. PubMed ID: 20979731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
    Bonello L; Sbragia P; Amabile N; Com O; Pierre SV; Levy S; Paganelli F
    Heart; 2007 Jun; 93(6):703-7. PubMed ID: 17488771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention].
    Xu XH; Zhang WJ; Zhou YJ; Zhou ZM; Ma HY; Hu B; Kang YP; Luo FF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):205-9. PubMed ID: 23879944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical benefits of trimetazidine in patients with recurrent angina.
    Szwed H
    Coron Artery Dis; 2004 May; 15 Suppl 1():S17-21. PubMed ID: 15179124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
    Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
    Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical outcomes of trimetazidine in patients with acute ST segment elevation myocardial infarction without ST segment resolution after primary percutaneous coronary intervention].
    Peng JJ; Ma ZM; Ren WL; Ren LH; Lei LC; Liang Y
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1399-401. PubMed ID: 19671333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind study at 2-year follow-up.
    Xu X; Zhang W; Zhou Y; Zhao Y; Liu Y; Shi D; Zhou Z; Ma H; Wang Z; Yu M; Ma Q; Gao F; Shen H; Zhang J
    Clin Drug Investig; 2014 Apr; 34(4):251-8. PubMed ID: 24470342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Kazmi DH; Kapoor A; Sinha A; Ambesh P; Kashyap S; Khanna R; Kumar S; Garg N; Tewari S; Goel PK
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S365-S371. PubMed ID: 30595291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study.
    Chu-fan L; Xing W; Xun H; Gui-fu W; Cheng-heng H; Zhi-min D
    J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):790-4. PubMed ID: 21934521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
    Peng S; Zhao M; Wan J; Fang Q; Fang D; Li K
    Int J Cardiol; 2014 Dec; 177(3):780-5. PubMed ID: 25466565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
    Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
    Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.
    Birand A; Kudaiberdieva GZ; Batyraliev TA; Akgul F; Usal A
    Angiology; 1997 May; 48(5):413-22. PubMed ID: 9158385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M; Dernek S; Sevin B; Kural T
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
    Zhang Y; Ma XJ; Shi DZ
    PLoS One; 2015; 10(9):e0137775. PubMed ID: 26367001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimetazidine limits the effects of myocardial ischaemia during percutaneous coronary angioplasty.
    Poloński L; Dec I; Wojnar R; Wilczek K
    Curr Med Res Opin; 2002; 18(7):389-96. PubMed ID: 12487504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.